Skip to main content

Find Clinical Trials

Home
Conditions
Intermediate Risk Acute Myeloid Leukemia

Clinical trial condition

Intermediate Risk Acute Myeloid Leukemia

Explore clinical trials studying Intermediate Risk Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

3 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Intermediate Risk Acute Myeloid Leukemia trial results

Recruiting

VA Consolidation in Intermediate-Risk AML

NCT07672262

Conditions: Acute Myeloid Leukemia, Consolidation Therapy, Hematologic Diseases, +7 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML

NCT07259707

Conditions: Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication Positive, Fit Patients, +8 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients

NCT06394011

Conditions: High Risk Acute Myeloid Leukemia, Intermediate Risk Acute Myeloid Leukemia
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details